Optimizing Care for Patients with Myelodysplastic Syndrome (MDS)
Learning Objectives
- Characterize the current treatment landscape in defining the applicability of emerging trial outcomes in Canadian practice
- Share Key Opinion Leader best practices for implementation of novel treatment selection and management into clinical practice
- Improve outcomes for patients with MDS
Moderator
Dr. Rena Buckstein
Panelists
Dr. Heather Leitch
Dr. Brett Houston
This program has been made possible through unrestricted support from Taiho